BEAM - Beam Therapeutics Inc Company Long-Term Debt

Graphic logo of Beam Tx (BEAM)

Beam Therapeutics Inc. (BEAM) dominates the gene therapy niche thanks to its innovative DNA base editing method. Changes in the issuer's long-term liabilities allow for an assessment of the credit load, with 0.25 recorded as the baseline value. Strict bio-waste control minimizes environmental impact, while strategic patent management and partnerships with industry behemoths ensure sustainable business development.

Beam Therapeutics Inc. (BEAM) Company Long-Term Debts: for the period 07/04/2022 - 10/31/2026

Beam Therapeutics Corp - analytical breakdowns and key metrics (BEAM)

- market price and analyst price targets:
Stock Price beamtx.com|BEAM - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Beam Therapeutics|BEAM - Enterprise Value
- business book valuation details:
Net Asset Value per Share Beam Therapeutics|BEAM - Book Capitalization|Market Capitalization to Book Value Ratio beamtx.com|BEAM - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Beam Therapeutics Inc.|BEAM - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Beam Tx|BEAM - Company Total Debt|Debt to Book Capital Beam Therapeutics|BEAM - Company Long-Term Debts|Company Short-Term Loans and Borrowings Beam Therapeutics|Immediate Liquidity beamtx.com
- earnings and market multiples details:
BEAM - Company Net Income
Fundamental company valuation:beamtx.com BEAM
Mass-produced product of Beam Tx

Beam Therapeutics Inc. (BEAM) is developing high-tech DNA editing based on its own proprietary research and strategic alliances with pharmaceutical corporations. The total amount of long-term liabilities reflects the volume of borrowed funds with a maturity of more than one year, which allows for an assessment of the balance between R&D investments and the financial stability of the issuer's structure through the time series of the business's long-term debt capital.

Who Beam Therapeutics Inc. competes with

Company Long-Term Debts Tempus Labs TEM|Qiagen - Company Long-Term Debts|IONS: Company Long-Term Debt|RGEN: Company Long-Term Debts|Long-Term Debt Avidity Corp (RNA)|CRSP (CRISPR Therapeutics AG) - Company Long-Term Debts|Company Long-Term Debts genedx.com|Company Long-Term Debt Ultragenyx (RARE)|Company Long-Term Liabilities Sarepta Therapeutics SRPT|Twist Bio - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings TXG|NTLA: Company Long-Term Liabilities|stoketherapeutics.com - Amount of Long-Term Liabilities|BLFS: Company Long-Term Debts|Wave Life Sciences Ltd - Company Long-Term Loans and Borrowings|MAZE (Maze Tx) - Company Long-Term Debts|Long-Term Debt Sionna Corp SION|Company Long-Term Debt Prime Medicine, Inc. (PRME)|TSHA (tayshagtx.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts QURE (uniQure)|Company Long-Term Debts MeiraGTx Holdings MGTX|RGNX - Company Long-Term Debt|Long-Term Liabilities SLDB|OCGN: Company Long-Term Debts|Long-Term Debt pacb.com (PACB)|Company Long-Term Liabilities BNTC|Company Long-Term Debts Design Therapeutics Inc|Company Long-Term Liabilities RCKT (Rocket Pharmaceuticals Inc)|Amount of Long-Term Liabilities FDMT|Company Long-Term Debts LXEO (Lexeo Therapeutics, Inc.)|Long-Term Debt Volume Korro Bio Inc. (KRRO)|Editas Medicine - Company Long-Term Debts|Silence Therapeutics PLC (SLN) - Company Long-Term Liabilities|proqr.com (PRQR) - Company Long-Term Debt|CDXS - Long-Term Debt Volume|Company Long-Term Liabilities SGMO|NAUT: Company Long-Term Loans and Borrowings|Company Long-Term Debts MGX|Long-Term Debt Volume Precision BioSciences Inc.|Company Long-Term Debt Generation Bio GBIO|BOLD: Company Long-Term Indebtedness|Exicure Corp - Company Long-Term Debts|Imunon, Inc. (IMNN) - Company Long-Term Liabilities|PHIO (phiopharma.com) - Company Long-Term Liabilities|MBIO - Long-Term Debt Volume|RNAZ (TransCode Therapeutics Inc.) - Company Long-Term Debts|Company Long-Term Debt BNGO|Company Long-Term Debts APDN|BLUE - Long-Term Debt|Company Long-Term Debts IPA (ImmunoPrecise Antibodies Ltd.)|Company Long-Term Debts Omega Therapeutics Inc OMGA|OMIC - Company Long-Term Debt|Regulus (RGLS) - Company Long-Term Liabilities|SYRS: Company Long-Term Debts|Company Long-Term Indebtedness TBIO|Company Long-Term Debt TRACON Pharmaceuticals, Inc.|Company Long-Term Indebtedness UBX (Unity Biotechnology Inc.)